| Authors: |
Bernard A; Inserm U1231, Dijon, France., Chevrier S; Department of Biology and Pathology of Tumors, Georges-Francois Leclerc Cancer Center-UNICANCER, Dijon, France., Beltjens F; Department of Biology and Pathology of Tumors, Georges-Francois Leclerc Cancer Center-UNICANCER, Dijon, France., Dosset M; Inserm U1231, Dijon, France., Viltard E; Inserm U1231, Dijon, France., Lagrange A; Inserm U1231, Dijon, France., Derangère V; Inserm U1231, Dijon, France.; Platform of Transfer in Cancer Biology, Georges-Francois Leclerc Cancer Center-UNICANCER, Dijon, France., Oudot A; Preclinical Imaging Platform-Nuclear Medicine Department, Georges-Francois Leclerc Cancer Center-UNICANCER, Dijon, France., Ghiringhelli F; Inserm U1231, Dijon, France.; Platform of Transfer in Cancer Biology, Georges-Francois Leclerc Cancer Center-UNICANCER, Dijon, France., Collin B; Preclinical Imaging Platform-Nuclear Medicine Department, Georges-Francois Leclerc Cancer Center-UNICANCER, Dijon, France., Apetoh L; Inserm U1231, Dijon, France., Feron O; Pole of Pharmacology and Therapeutics, Institut de Recherche Expérimentale et Clinique, UCLouvain, Brussels, Belgium., Chen S; Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey.; The Cancer Institute of New Jersey, New Brunswick, New Jersey., Arnould L; Department of Biology and Pathology of Tumors, Georges-Francois Leclerc Cancer Center-UNICANCER, Dijon, France., Végran F; Inserm U1231, Dijon, France.; Platform of Transfer in Cancer Biology, Georges-Francois Leclerc Cancer Center-UNICANCER, Dijon, France., Boidot R; Inserm U1231, Dijon, France. rboidot@cgfl.fr.; Department of Biology and Pathology of Tumors, Georges-Francois Leclerc Cancer Center-UNICANCER, Dijon, France. |
